![]() | Only 14 pages are availabe for public view |
Abstract Aim of the work 1- To assess the frequency of ototoxicity and associated risk factors in survivors of childhood cancer receiving platinum-based chemotherapy. 2- To assess the frequency of the genetic variant: GSTP1 c.313A>G (rs1695) in survivors of childhood cancer who received platinum-based chemotherapy. 3- To detect relation between GSTP1 (rs1695) polymorphism and ototoxicity caused by platinum-based chemotherapy |